vs
帕可Bio（PACB）与Planet Labs PBC（PL）财务数据对比。点击上方公司名可切换其他公司
Planet Labs PBC的季度营收约是帕可Bio的1.8倍（$81.3M vs $44.6M），Planet Labs PBC净利率更高（-72.8% vs -90.4%，领先17.6%），Planet Labs PBC同比增速更快（32.6% vs 13.8%），Planet Labs PBC自由现金流更多（$1.9M vs $-19.9M），过去两年Planet Labs PBC的营收复合增速更高（17.5% vs 7.3%）
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
Planet Labs PBC（常简称为Planet）是总部位于美国加利福尼亚州旧金山的上市地球影像企业，核心目标是实现全球范围的每日成像，以此监测地表变化、精准识别相关趋势，为多行业的地理数据分析需求提供可靠的数据支持。
PACB vs PL — 直观对比
营收规模更大
PL
是对方的1.8倍
$44.6M
营收增速更快
PL
高出18.8%
13.8%
净利率更高
PL
高出17.6%
-90.4%
自由现金流更多
PL
多$21.8M
$-19.9M
两年增速更快
PL
近两年复合增速
7.3%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $44.6M | $81.3M |
| 净利润 | $-40.4M | $-59.2M |
| 毛利率 | 37.1% | 57.3% |
| 营业利润率 | -92.3% | -22.6% |
| 净利率 | -90.4% | -72.8% |
| 营收同比 | 13.8% | 32.6% |
| 净利润同比 | -1802.7% | -194.7% |
| 每股收益（稀释后） | $-0.11 | $-0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PACBPL
| Q4 25 | $44.6M | $81.3M | ||
| Q3 25 | $38.4M | $73.4M | ||
| Q2 25 | $39.8M | $66.3M | ||
| Q1 25 | $37.2M | $61.6M | ||
| Q4 24 | $39.2M | $61.3M | ||
| Q3 24 | $40.0M | $61.1M | ||
| Q2 24 | $36.0M | $60.4M | ||
| Q1 24 | $38.8M | $58.9M |
净利润PACBPL
| Q4 25 | $-40.4M | $-59.2M | ||
| Q3 25 | $-38.0M | $-22.6M | ||
| Q2 25 | $-41.9M | $-12.6M | ||
| Q1 25 | $-426.1M | $-35.2M | ||
| Q4 24 | $2.4M | $-20.1M | ||
| Q3 24 | $-60.7M | $-38.7M | ||
| Q2 24 | $-173.3M | $-29.3M | ||
| Q1 24 | $-78.2M | $-30.1M |
毛利率PACBPL
| Q4 25 | 37.1% | 57.3% | ||
| Q3 25 | 41.4% | 57.6% | ||
| Q2 25 | 36.9% | 55.2% | ||
| Q1 25 | -3.7% | 62.1% | ||
| Q4 24 | 25.6% | 61.2% | ||
| Q3 24 | 25.0% | 52.9% | ||
| Q2 24 | 16.5% | 52.4% | ||
| Q1 24 | 29.1% | 55.2% |
营业利润率PACBPL
| Q4 25 | -92.3% | -22.6% | ||
| Q3 25 | -101.1% | -24.5% | ||
| Q2 25 | -112.8% | -34.4% | ||
| Q1 25 | -1154.5% | -31.5% | ||
| Q4 24 | -390.1% | -36.9% | ||
| Q3 24 | -160.3% | -64.8% | ||
| Q2 24 | -488.3% | -57.2% | ||
| Q1 24 | -209.6% | -57.6% |
净利率PACBPL
| Q4 25 | -90.4% | -72.8% | ||
| Q3 25 | -98.9% | -30.8% | ||
| Q2 25 | -105.4% | -19.1% | ||
| Q1 25 | -1146.8% | -57.1% | ||
| Q4 24 | 6.0% | -32.8% | ||
| Q3 24 | -151.9% | -63.3% | ||
| Q2 24 | -481.3% | -48.5% | ||
| Q1 24 | -201.4% | -51.1% |
每股收益（稀释后）PACBPL
| Q4 25 | $-0.11 | $-0.19 | ||
| Q3 25 | $-0.13 | $-0.07 | ||
| Q2 25 | $-0.14 | $-0.04 | ||
| Q1 25 | $-1.44 | $-0.12 | ||
| Q4 24 | $-0.44 | $-0.07 | ||
| Q3 24 | $-0.22 | $-0.13 | ||
| Q2 24 | $-0.64 | $-0.10 | ||
| Q1 24 | $-0.29 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $279.5M | $443.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.3M | $349.6M |
| 总资产 | $784.1M | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PACBPL
| Q4 25 | $279.5M | $443.3M | ||
| Q3 25 | $298.7M | $181.1M | ||
| Q2 25 | $314.7M | $133.5M | ||
| Q1 25 | $343.1M | $118.0M | ||
| Q4 24 | $389.9M | $139.0M | ||
| Q3 24 | $471.1M | $148.3M | ||
| Q2 24 | $509.8M | $107.4M | ||
| Q1 24 | $561.9M | $83.9M |
股东权益PACBPL
| Q4 25 | $5.3M | $349.6M | ||
| Q3 25 | $36.1M | $435.7M | ||
| Q2 25 | $61.5M | $444.8M | ||
| Q1 25 | $91.6M | $441.3M | ||
| Q4 24 | $506.6M | $464.6M | ||
| Q3 24 | $453.1M | $473.2M | ||
| Q2 24 | $492.7M | $500.3M | ||
| Q1 24 | $649.0M | $518.0M |
总资产PACBPL
| Q4 25 | $784.1M | $1.1B | ||
| Q3 25 | $803.2M | $696.4M | ||
| Q2 25 | $825.5M | $658.4M | ||
| Q1 25 | $860.8M | $633.8M | ||
| Q4 24 | $1.3B | $630.8M | ||
| Q3 24 | $1.5B | $658.4M | ||
| Q2 24 | $1.5B | $674.6M | ||
| Q1 24 | $1.7B | $702.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.1M | $28.6M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | $1.9M |
| 自由现金流率自由现金流/营收 | -44.6% | 2.3% |
| 资本支出强度资本支出/营收 | 1.9% | 32.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-114.1M | $40.7M |
8季度趋势，按日历期对齐
经营现金流PACBPL
| Q4 25 | $-19.1M | $28.6M | ||
| Q3 25 | $-18.7M | $67.8M | ||
| Q2 25 | $-29.4M | $17.3M | ||
| Q1 25 | $-44.1M | $-6.3M | ||
| Q4 24 | $-30.6M | $4.1M | ||
| Q3 24 | $-45.5M | $-7.9M | ||
| Q2 24 | $-54.3M | $-4.3M | ||
| Q1 24 | $-75.7M | $-6.8M |
自由现金流PACBPL
| Q4 25 | $-19.9M | $1.9M | ||
| Q3 25 | $-18.8M | $47.5M | ||
| Q2 25 | $-29.9M | $9.2M | ||
| Q1 25 | $-45.4M | $-17.9M | ||
| Q4 24 | $-32.3M | $-3.6M | ||
| Q3 24 | $-46.3M | $-23.0M | ||
| Q2 24 | $-55.7M | $-14.2M | ||
| Q1 24 | $-79.6M | $-15.7M |
自由现金流率PACBPL
| Q4 25 | -44.6% | 2.3% | ||
| Q3 25 | -48.9% | 64.7% | ||
| Q2 25 | -75.3% | 13.9% | ||
| Q1 25 | -122.3% | -29.1% | ||
| Q4 24 | -82.3% | -5.8% | ||
| Q3 24 | -115.7% | -37.6% | ||
| Q2 24 | -154.8% | -23.6% | ||
| Q1 24 | -205.0% | -26.7% |
资本支出强度PACBPL
| Q4 25 | 1.9% | 32.9% | ||
| Q3 25 | 0.2% | 27.6% | ||
| Q2 25 | 1.4% | 12.3% | ||
| Q1 25 | 3.7% | 18.9% | ||
| Q4 24 | 4.1% | 12.5% | ||
| Q3 24 | 2.0% | 24.8% | ||
| Q2 24 | 4.1% | 16.4% | ||
| Q1 24 | 10.0% | 15.1% |
现金转化率PACBPL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -12.93× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
PL
| Defense And Intelligence | $49.4M | 61% |
| Civil Government | $18.8M | 23% |
| Commercial | $13.1M | 16% |
